Free Trial
LON:AVCT

Avacta Group (AVCT) Share Price, News & Analysis

Avacta Group logo
GBX 31.75 +0.25 (+0.79%)
As of 11:45 AM Eastern

About Avacta Group Stock (LON:AVCT)

Key Stats

Today's Range
30.65
32
50-Day Range
27.50
38
52-Week Range
26
86.40
Volume
718,986 shs
Average Volume
1.79 million shs
Market Capitalization
£120.62 million
P/E Ratio
N/A
Dividend Yield
3.97%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AVCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avacta Group and its competitors with MarketBeat's FREE daily newsletter.

AVCT Stock News Headlines

AVCT - Avacta Group PLC Sustainability - Morningstar
Avacta Group Regulatory News
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Avacta Group PLC
See More Headlines

AVCT Stock Analysis - Frequently Asked Questions

Avacta Group's stock was trading at GBX 53.50 on January 1st, 2025. Since then, AVCT shares have decreased by 40.7% and is now trading at GBX 31.75.

Avacta Group Plc (LON:AVCT) issued its quarterly earnings results on Friday, June, 6th. The biotechnology company reported ($8.54) EPS for the quarter. Avacta Group had a negative net margin of 114.45% and a negative trailing twelve-month return on equity of 74.00%.

Shares of AVCT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Avacta Group investors own include Legal & General Group (LGEN), Lloyds Banking Group (LLOY), Lloyds Banking Group (LYG), IQE (IQE), Barclays (BARC), Meta Platforms (META) and Revvity (PKI).

Company Calendar

Last Earnings
6/06/2025
Today
7/10/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:AVCT
CIK
N/A
Fax
N/A
Employees
120
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (7.77)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£30.08 million
Net Margins
-114.45%
Pretax Margin
N/A
Return on Equity
-74.00%
Return on Assets
-21.80%

Debt

Debt-to-Equity Ratio
52.53
Current Ratio
1.29
Quick Ratio
4.96

Sales & Book Value

Annual Sales
£26.29 million
Price / Sales
4.59
Cash Flow
GBX 2.12 per share
Price / Cash Flow
15.00
Book Value
GBX 14.73 per share
Price / Book
2.16

Miscellaneous

Outstanding Shares
379,910,747
Free Float
N/A
Market Cap
£120.62 million
Optionable
Not Optionable
Beta
1.12
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (LON:AVCT) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners